First Light Asset Management LLC Has $38.94 Million Position in LivaNova PLC (NASDAQ:LIVN)

First Light Asset Management LLC increased its position in LivaNova PLC (NASDAQ:LIVN) by 591.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 710,390 shares of the company’s stock after purchasing an additional 607,598 shares during the quarter. LivaNova makes up 3.4% of First Light Asset Management LLC’s holdings, making the stock its 12th largest position. First Light Asset Management LLC owned about 1.31% of LivaNova worth $38,944,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the company. Campbell & CO Investment Adviser LLC bought a new stake in shares of LivaNova during the 4th quarter worth about $2,090,000. Trexquant Investment LP bought a new stake in LivaNova in the 4th quarter valued at $1,079,000. Norges Bank acquired a new position in LivaNova in the 4th quarter valued at $26,064,000. BNP Paribas Financial Markets lifted its holdings in shares of LivaNova by 88.6% during the first quarter. BNP Paribas Financial Markets now owns 42,121 shares of the company’s stock worth $2,356,000 after buying an additional 19,783 shares in the last quarter. Finally, Great Lakes Advisors LLC bought a new stake in shares of LivaNova in the second quarter valued at about $16,614,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Stifel Nicolaus increased their target price on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. Needham & Company LLC lifted their price objective on LivaNova from $72.00 to $75.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. Finally, Robert W. Baird upgraded LivaNova from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $66.00 in a research report on Tuesday, September 17th. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $70.80.

LivaNova Stock Performance

NASDAQ:LIVN opened at $51.31 on Tuesday. The company has a quick ratio of 2.94, a current ratio of 3.45 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $2.78 billion, a PE ratio of -85.52 and a beta of 1.00. LivaNova PLC has a twelve month low of $42.75 and a twelve month high of $64.47. The stock’s 50-day simple moving average is $48.83 and its 200 day simple moving average is $53.36.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.15. LivaNova had a negative net margin of 1.37% and a positive return on equity of 13.77%. The business had revenue of $318.60 million during the quarter, compared to analysts’ expectations of $305.05 million. On average, analysts anticipate that LivaNova PLC will post 2.58 EPS for the current fiscal year.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.